MINAPHARM Pharmaceuticals (EGX:MIPH)

MINAPHARM Pharmaceuticals Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 7, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,902	2,408	1,822	1,303	987	1,044
Market Cap Growth	-20.20%	32.19%	39.82%	32.02%	-5.49%	-3.47%
Enterprise Value	4,460	4,087	2,625	1,448	1,101	1,396
Last Close Price	171.87	215.89	145.12	101.77	75.10	73.62
PE Ratio	-	-	3.09	2.91	3.46	7.40
PS Ratio	0.43	0.62	0.50	0.43	0.42	0.51
PB Ratio	0.44	0.69	0.60	0.67	0.62	0.78
P/TBV Ratio	0.47	0.80	0.70	0.81	0.79	1.05
P/FCF Ratio	-	-	-	3.44	-
P/OCF Ratio	10.77	22.79	3.24	6.29	2.26	5.07
EV/Sales Ratio	1.01	1.05	0.73	0.48	0.47	0.68
EV/EBITDA Ratio	7.16	7.63	2.42	1.73	1.77	3.87
EV/EBIT Ratio	12.76	10.91	2.72	1.92	2.04	4.72
EV/FCF Ratio	-6.26	-	-	-	3.84	-
Debt / Equity Ratio	1.27	1.08	0.80	0.64	0.60	0.66
Debt / EBITDA Ratio	9.04	6.71	2.22	1.49	1.54	2.47
Debt / FCF Ratio	-	-	-	-	3.34	-
Asset Turnover	-	0.50	0.66	0.79	0.74	0.73
Inventory Turnover	-	2.79	2.82	2.90	2.73	2.87
Quick Ratio	0.78	0.69	0.87	0.92	0.84	0.70
Current Ratio	1.17	1.15	1.46	1.61	1.34	1.22
Return on Equity (ROE)	-	0.68%	25.32%	26.86%	21.14%	10.89%
Return on Assets (ROA)	-	3.02%	11.05%	12.42%	10.56%	6.57%
Return on Capital (ROIC)	-	3.66%	13.92%	16.41%	14.07%	8.36%
Return on Capital Employed (ROCE)	4.90%	7.20%	22.40%	28.80%	29.10%	19.80%
Earnings Yield	-10.01%	-1.33%	33.63%	35.79%	30.47%	13.51%
FCF Yield	-37.44%	-53.66%	-32.84%	-13.86%	29.06%	-3.67%
Dividend Yield	0.96%	0.76%	1.93%	2.87%	3.60%	-
Payout Ratio	0.00%	-	9.43%	10.68%	29.33%	67.42%
Buyback Yield / Dilution	0.80%	3.57%	6.67%	-	-	-
Total Shareholder Return	1.76%	4.33%	8.60%	2.87%	3.60%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.